Elevated C-reactive protein in depression: A predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy

Journal of Psychopharmacology

Volumn 24, Issue 4, 2010, Pages 625-626

  Harley, J ^a   Luty, S ^a   Carter, J ^b   Mulder, R ^a   Joyce, P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; FLUOXETINE; HAPTOGLOBIN; NORTRIPTYLINE; OROSOMUCOID;

CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFLAMMATION; LETTER; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; STRUCTURED INTERVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSION; HUMANS; INFLAMMATION MEDIATORS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 77950396969     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102770     Document Type: Letter

References (9)

1. Danese, A., Moffitt, TE, Pariante, CM, Ambler, A., Poulton, R., Caspi, A. (2008) Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65: 409-415. (Pubitemid 351519890)
2. Joyce, PR, Mulder, RT, Luty, SE, Sullivan, PF, McKenzie, JM, Abbott, RM, et al. (2002) Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 36: 384-391.
3. Kuo, HK, Yen, CJ, Chang, CH, Kuo, CK, Chen, JH, Sorond, F. (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4: 371-380. (Pubitemid 40720034)
4. Lanquillon, S., Krieg, JC, Bening-Abu-Shach, U., Vedder, H. (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379. (Pubitemid 30105765)
5. Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Räsänen, P., Leinonen, M., Meyer-Rochow, VB, et al. (2006) The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60: 825-830. (Pubitemid 44550038)
6. Luty, SE, Carter, JD, McKenzie, JM, Rae, AM, Frampton, CM, Mulder, RT, et al. (2007) Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 190: 496-502. (Pubitemid 46868833)
7. OBrien, SM, Scott, LV, Dinan, TG (2006) Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 188: 449-452.
8. Tuglu, C., Kara, SH, Caliyurt, O., Vardar, E., Abay, E. (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170: 429-433. (Pubitemid 38010515)
9. Whooley, MA, Caska, CM, Hendrickson, BE, Rourke, MA, Ho, J., Ali, S. (2007) Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 62: 314-320. (Pubitemid 47444281)